Immuneering Corporation Class A Common Stock (IMRX)

Typically moves ±4.99% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE

Immuneering Corporation Class A Common Stock (IMRX) has reported earnings 21 times since Sep 09, 2021. The stock moves an average of ±4.99% the day after reporting, closing higher 61.9% of the time. Its largest post-earnings gain was +15.04% (Nov 13, 2024) and its largest decline was -10.94% (Aug 06, 2024). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How IMRX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.99%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 05, 2026	☀ PRE	-0.91%	open_in_new
May 15, 2026	☀ PRE	+0.58%	open_in_new
Mar 06, 2026	☀ PRE	+6.83%	open_in_new
Nov 12, 2025	☽ POST	-2.58%	open_in_new
Aug 13, 2025	☽ POST	-6.35%	open_in_new
May 05, 2025	☽ POST	-2.4%	open_in_new
Mar 20, 2025	☽ POST	+9.15%	open_in_new
Nov 13, 2024	☽ POST	+15.04%	open_in_new
Aug 06, 2024	☽ POST	-10.94%	open_in_new
May 07, 2024	☽ POST	+4.49%	open_in_new
Mar 01, 2024	☀ PRE	+0%	open_in_new
Nov 09, 2023	☽ POST	+1.05%	open_in_new
Aug 03, 2023	☽ POST	+3.37%	open_in_new
Apr 18, 2023	☀ PRE	+7.89%	open_in_new
Mar 06, 2023	☽ POST	+8.45%	open_in_new
Nov 10, 2022	☀ PRE	-4.17%	open_in_new
Aug 10, 2022	☽ POST	+0.69%	open_in_new
May 10, 2022	☀ PRE	+14.35%	open_in_new
Mar 10, 2022	☀ PRE	-0.57%	open_in_new
Nov 09, 2021	☀ PRE	-3.34%	open_in_new
Sep 09, 2021	☀ PRE	+1.66%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.99%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 18 →

Funds holding

$48811719

Total value held

Buying

13 added · 5 reduced

Blackrock, Inc.

$21826360 +190.20%

Sanofi

$13515709 NEW BUY

State Street Corp

$4999955 +273.15%

Ubs Group Ag

$2239796 NEW BUY

Northern Trust Corp

$2180590 +271.38%

SEC Filing Types

description SCHEDULE 13G

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
10-Q	20260805	open_in_new SEC.gov
8-K	20260805	open_in_new SEC.gov
SCHEDULE 13G	20260728	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
3	20260716	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260616	open_in_new SEC.gov
8-K	20260615	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov
4	20260611	open_in_new SEC.gov

Frequently asked about IMRX earnings

When does Immuneering Corporation Class A Common Stock report earnings next? expand_more

Immuneering Corporation Class A Common Stock (IMRX)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does IMRX stock move after earnings? expand_more

Over 21 reports, IMRX has moved an average of ±4.99% the session after earnings, closing higher 61.9% of the time.

What was IMRX's biggest post-earnings move? expand_more

IMRX's largest post-earnings gain on record was +15.04% on Nov 13, 2024, and its largest decline was -10.94% on Aug 06, 2024.

Where can I find Immuneering Corporation Class A Common Stock's SEC filings? expand_more

All of Immuneering Corporation Class A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.